Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.

All products featured on Architectural Digest are independently selected by our editors. However, when you buy something through our retail links, we may earn an affiliate commission. Designing a ...

A Florida circuit judge on Monday denied the Pulitzer Board’s request to pause a defamation lawsuit from Donald Trump until the president is out of office. The decision from the 19th Judicial ...

President Donald Trump scored yet another victory in his legal battle against the members of the Pulitzer Prize Board after a judge denied their request for a temporary stay on his lawsuit against ...

Guthrie Theater artistic director Joseph Haj will direct Matthew Lopez's 1950's-set play, "Somewhere," for the 2025-26 season. (Star Tribune/The Minnesota Star Tribune) ...

— Recommendations are independently chosen by our editors. Purchases you make through our links may earn us and our publishing partners a commission. Few things in life feel quite as luxurious ...

There's a new Spotify bedroom trend that initially started with the "Make Your Internet Bedroom" tool on Verse. It essentially creates a custom room based on your music taste by connecting to your ...

Earlier this week, Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial Zepbound (tirzepatide) to patients in the virtual care companies ...

Eli Lilly (LLY) ended the recent trading session at $912.76, demonstrating a -1.82% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 1.78%.